O
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K185.4 KBOncternal Therapeutics, Inc.Nov 25, 6:03 AM ET·0000950170-24-130415
- 8-K187.3 KBOncternal Therapeutics, Inc.Nov 14, 5:08 PM ET·0000950170-24-127184
- 10-Q6.5 MBOncternal Therapeutics, Inc.Nov 6, 4:30 PM ET·0000950170-24-122383
- 8-K193.2 KBOncternal Therapeutics, Inc.Sep 12, 4:49 PM ET·0000950170-24-105987
- 10-Q6.7 MBOncternal Therapeutics, Inc.Aug 8, 4:30 PM ET·0000950170-24-094082
- 8-K302.3 KBOncternal Therapeutics, Inc.Aug 8, 4:10 PM ET·0000950170-24-093953
- 8-K172.1 KBOncternal Therapeutics, Inc.Jun 21, 4:05 PM ET·0000950170-24-076218
- 10-Q6.0 MBOncternal Therapeutics, Inc.May 9, 4:17 PM ET·0000950170-24-057008
- 8-K277.0 KBOncternal Therapeutics, Inc.May 9, 4:05 PM ET·0000950170-24-056882
- 10-K11.7 MBOncternal Therapeutics, Inc.Mar 7, 4:20 PM ET·0000950170-24-027984
Insiders
10- AKER HAZEL MGeneral Counsel
- BARNETTE K GARYVice President
- BILINSKY IGORChief Business Officer
- BREITMEYER JAMES BDirector, President, CEO
- CARTER MICHAEL GDirector
- Chen Jinzhu PhDDirector
- Cho ManDirector
- DALTON JAMES TVP, Chief Scientific Officer
- DEENER GREGORY AVice President
- DOGGRELL HENRY PATTONVice President and Secretary
Tickers
No tickers on record
Addresses
business
12230 EL CAMINO REAL SUITE 230
SAN DIEGO, CA, 92130
mailing
12230 EL CAMINO REAL SUITE 230
SAN DIEGO, CA, 92130
Former Names
- GTX INC /DE/2019-06-11
- GTX INC/TN2004-01-15